David E. Ehmann

3.0k total citations
29 papers, 2.2k citations indexed

About

David E. Ehmann is a scholar working on Molecular Biology, Pharmacology and Molecular Medicine. According to data from OpenAlex, David E. Ehmann has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Pharmacology and 12 papers in Molecular Medicine. Recurrent topics in David E. Ehmann's work include Antibiotic Resistance in Bacteria (12 papers), Cancer therapeutics and mechanisms (10 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). David E. Ehmann is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Cancer therapeutics and mechanisms (10 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). David E. Ehmann collaborates with scholars based in United States, United Kingdom and Canada. David E. Ehmann's co-authors include Christopher T. Walsh, Stewart L. Fisher, Rong-Fang Gu, Haris Jahić, Grant K. Walkup, Philip L. Ross, Jun Hu, Sushmita D. Lahiri, Günther Kern and Jason Thresher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

David E. Ehmann

29 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Ehmann United States	22	1.1k	1.0k	994	334	270	29	2.2k
Sushmita D. Lahiri United States	28	1.1k 1.0×	700 0.7×	1.0k 1.0×	371 1.1×	234 0.9×	41	2.3k
Kade D. Roberts Australia	26	1.1k 1.0×	713 0.7×	1.0k 1.0×	327 1.0×	370 1.4×	57	2.3k
Philip Hinchliffe United Kingdom	21	1.3k 1.2×	536 0.5×	1.2k 1.2×	406 1.2×	130 0.5×	43	2.6k
Carine Bebrone Belgium	22	1.3k 1.2×	483 0.5×	641 0.6×	343 1.0×	224 0.8×	30	1.9k
Dustin T. King Canada	19	952 0.8×	454 0.5×	777 0.8×	277 0.8×	296 1.1×	32	1.7k
Jürgen Brem United Kingdom	28	1.8k 1.6×	852 0.8×	1.0k 1.0×	757 2.3×	371 1.4×	88	2.7k
Filomena De Luca Italy	20	1.1k 1.0×	487 0.5×	466 0.5×	311 0.9×	140 0.5×	41	1.5k
Emilia Caselli Italy	25	869 0.8×	478 0.5×	1.1k 1.1×	347 1.0×	528 2.0×	52	2.2k
John D. Buynak United States	28	1.0k 0.9×	570 0.6×	594 0.6×	262 0.8×	760 2.8×	89	2.0k
Fabio Prati Italy	31	1.1k 1.0×	533 0.5×	1.1k 1.1×	396 1.2×	990 3.7×	115	2.6k

Countries citing papers authored by David E. Ehmann

Since Specialization

Citations

This map shows the geographic impact of David E. Ehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Ehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Ehmann more than expected).

Fields of papers citing papers by David E. Ehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Ehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Ehmann. The network helps show where David E. Ehmann may publish in the future.

Co-authorship network of co-authors of David E. Ehmann

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Ehmann. A scholar is included among the top collaborators of David E. Ehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Ehmann. David E. Ehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ehmann, David E., et al.. (2023). Chronic retinal detachment with hemorrhagic macrocysts. Canadian Journal of Ophthalmology. 58(5). e202–e202. 1 indexed citations

Chen, Nancy, David E. Ehmann, Katayoun Derakhchan, et al.. (2023). Gene therapy for cross-correction of somatic organs and the CNS in mucopolysaccharidosis II in rodents and non-human primates. Molecular Therapy — Methods & Clinical Development. 29. 286–302. 4 indexed citations

Liu, Nan, Yan Huang, Jing Pan, et al.. (2018). Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone. Skeletal Muscle. 8(1). 34–34. 36 indexed citations

He, Tao, Matthew J. Traylor, Sheng Gu, et al.. (2018). Protein Engineering on Human Recombinant Follistatin: Enhancing Pharmacokinetic Characteristics for Therapeutic Application. Journal of Pharmacology and Experimental Therapeutics. 366(2). 291–302. 12 indexed citations

Kern, Günther, Tiffany Palmer, David E. Ehmann, et al.. (2015). Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914. Journal of Biological Chemistry. 290(34). 20984–20994. 39 indexed citations

Walkup, Grant K., Philip L. Ross, Fereidoon Daryaee, et al.. (2015). Translating slow-binding inhibition kinetics into cellular and in vivo effects. Nature Chemical Biology. 11(6). 416–423. 116 indexed citations

Penwell, William F., Adam B. Shapiro, R.A. Giacobbe, et al.. (2015). Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 59(3). 1680–1689. 183 indexed citations

Nayar, Asha S., Thomas J. Dougherty, Folkert Reck, et al.. (2014). Target-Based Resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a Novel Bacterial Type II Topoisomerase Inhibitor. Antimicrobial Agents and Chemotherapy. 59(1). 331–337. 21 indexed citations

Ehmann, David E. & Sushmita D. Lahiri. (2014). Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase. Current Opinion in Pharmacology. 18. 76–83. 63 indexed citations

10.

Lahiri, Sushmita D., Stefano Mangani, Haris Jahić, et al.. (2014). Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48. ACS Chemical Biology. 10(2). 591–600. 90 indexed citations

11.

Ehmann, David E., Haris Jahić, Philip L. Ross, et al.. (2013). Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases. Journal of Biological Chemistry. 288(39). 27960–27971. 301 indexed citations

12.

Ehmann, David E., Haris Jahić, Philip L. Ross, et al.. (2012). Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor. Proceedings of the National Academy of Sciences. 109(29). 11663–11668. 410 indexed citations

13.

Jahić, Haris, et al.. (2012). The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds. Biochemical Pharmacology. 84(5). 654–660. 7 indexed citations

14.

Reck, Folkert, Richard A. Alm, Patrick Brassil, et al.. (2012). Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pK_a: Antibacterial Agents with an Improved Safety Profile. Journal of Medicinal Chemistry. 55(15). 6916–6933. 65 indexed citations

15.

Reck, Folkert, Richard A. Alm, Patrick Brassil, et al.. (2011). Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity. Journal of Medicinal Chemistry. 54(22). 7834–7847. 86 indexed citations

16.

Shapiro, Adam B., Haris Jahić, Swati Prasad, et al.. (2010). A Homogeneous, High-Throughput Fluorescence Anisotropy-Based DNA Supercoiling Assay. SLAS DISCOVERY. 15(9). 1088–1098. 24 indexed citations

17.

Ehmann, David E., et al.. (2003). Biochemical characterization of an inhibitor of Escherichia coli UDP-N-acetylmuramyl-l-alanine ligase. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1698(2). 167–174. 34 indexed citations

18.

Keating, Thomas A., David E. Ehmann, Rahul M. Kohli, et al.. (2001). Chain Termination Steps in Nonribosomal Peptide Synthetase Assembly Lines: Directed Acyl-S-Enzyme Breakdown in Antibiotic and Siderophore Biosynthesis. ChemBioChem. 2(2). 99–107. 62 indexed citations

19.

Ehmann, David E., John W. Trauger, Torsten Stachelhaus, & Christopher T. Walsh. (2000). Aminoacyl-SNACs as small-molecule substrates for the condensation domains of nonribosomal peptide synthetases. Chemistry & Biology. 7(10). 765–772. 97 indexed citations

20.

Keating, Thomas A., Zucai Suo, David E. Ehmann, & Christopher T. Walsh. (2000). Selectivity of the Yersiniabactin Synthetase Adenylation Domain in the Two-Step Process of Amino Acid Activation and Transfer to a Holo-Carrier Protein Domain. Biochemistry. 39(9). 2297–2306. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact